[Percutaneous transluminal coronary angioplasty for treatment of acute myocardial infarction: comparison with percutaneous transluminal coronary recanalization]. 1989

T Goto, and K Mitsudo, and K Matsunaga, and O Doi, and Y Nishihara, and J Awa, and T Hase, and T Sakamoto, and M Toda, and E Kou
Department of Cardiology, Kurashiki Central Hospital.

Percutaneous transluminal coronary angioplasty (PTCA) was evaluated as a means of reperfusion of the infarct-related coronary artery, and the results were compared with those of percutaneous transluminal coronary recanalization (PTCR). There were no difference in sex, age, infarct location and time from the onset to start of treatment between 135 patients with evolving acute myocardial infarction treated with PTCA (PTCA group) and 113 patients treated with PTCR alone (PTCR group). Fifty-nine patients in the PTCA group underwent PTCA following PTCR; the remaining 76 patients were without prior PTCR. Successful PTCA, defined as a 20% or more reduction in percent luminal stenosis diameter, was achieved in 123 (90%) of the 135 patients in the PTCA group. The reperfusion rate was 93% in the PTCA group and 77% in the PTCR group (p less than 0.01). Residual stenosis immediately after the treatment was 30 +/- 13% in the PTCA group and 70 +/- 16% in the PTCR group (p less than 0.01). In the PTCA group, three cases developed serious complications which were associated with angioplasty: coronary perforation, side branch occlusion resulting in cardiogenic shock and exacerbation of cardiogenic shock. The latter two patients died, however, there was no difference in hospital mortality rate: 6% in the PTCA group versus 11% in the PTCR group. At follow-up angiography performed four weeks after admission, reocclusion of the successfully recanalized arteries was observed in 3% of the PTCA group and in 14% of the PTCR group (p less than 0.01). Regional wall motion was evaluated by left ventriculography using a wall motion score system which consisted of six grades; from normal counted as 0, to dyskinesis counted as 5. There was no difference in the wall motion score between the successful PTCA group and the successful PTCR group (2.6 +/- 1.4 versus 2.8 +/- 1.4), but the scores of both groups were better than those of the non-recanalized group (3.4 +/- 1.0: p less than 0.01). In conclusion, PTCA and PTCR have the same effect on hospital mortality rate and regional wall motion, but PTCA has a higher reperfusion rate and a lower reocclusion rate than does PTCR. Although PTCA has a potential disadvantage inducing serious complications, it appears to be a useful treatment for acute myocardial infarction.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator
D015906 Angioplasty, Balloon, Coronary Dilation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply. Angioplasty, Coronary Balloon,Angioplasty, Transluminal, Percutaneous Coronary,Coronary Angioplasty, Transluminal Balloon,Percutaneous Transluminal Coronary Angioplasty,Balloon Dilation, Coronary Artery,Transluminal Coronary Balloon Dilation,Angioplasties, Coronary Balloon,Balloon Angioplasties, Coronary,Balloon Angioplasty, Coronary,Coronary Balloon Angioplasties,Coronary Balloon Angioplasty
D015912 Thrombolytic Therapy Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts. Fibrinolytic Therapy,Thrombolysis, Therapeutic,Therapeutic Thrombolysis,Therapy, Fibrinolytic,Therapy, Thrombolytic,Fibrinolytic Therapies,Therapeutic Thrombolyses,Therapies, Fibrinolytic,Therapies, Thrombolytic,Thrombolyses, Therapeutic,Thrombolytic Therapies

Related Publications

T Goto, and K Mitsudo, and K Matsunaga, and O Doi, and Y Nishihara, and J Awa, and T Hase, and T Sakamoto, and M Toda, and E Kou
January 1982, American heart journal,
T Goto, and K Mitsudo, and K Matsunaga, and O Doi, and Y Nishihara, and J Awa, and T Hase, and T Sakamoto, and M Toda, and E Kou
April 1993, Internal medicine (Tokyo, Japan),
T Goto, and K Mitsudo, and K Matsunaga, and O Doi, and Y Nishihara, and J Awa, and T Hase, and T Sakamoto, and M Toda, and E Kou
November 1989, Cardiology clinics,
T Goto, and K Mitsudo, and K Matsunaga, and O Doi, and Y Nishihara, and J Awa, and T Hase, and T Sakamoto, and M Toda, and E Kou
April 2003, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
T Goto, and K Mitsudo, and K Matsunaga, and O Doi, and Y Nishihara, and J Awa, and T Hase, and T Sakamoto, and M Toda, and E Kou
August 1994, Nihon rinsho. Japanese journal of clinical medicine,
T Goto, and K Mitsudo, and K Matsunaga, and O Doi, and Y Nishihara, and J Awa, and T Hase, and T Sakamoto, and M Toda, and E Kou
June 1986, Kyobu geka. The Japanese journal of thoracic surgery,
T Goto, and K Mitsudo, and K Matsunaga, and O Doi, and Y Nishihara, and J Awa, and T Hase, and T Sakamoto, and M Toda, and E Kou
January 1986, Kardiologia polska,
T Goto, and K Mitsudo, and K Matsunaga, and O Doi, and Y Nishihara, and J Awa, and T Hase, and T Sakamoto, and M Toda, and E Kou
April 2003, Nihon rinsho. Japanese journal of clinical medicine,
T Goto, and K Mitsudo, and K Matsunaga, and O Doi, and Y Nishihara, and J Awa, and T Hase, and T Sakamoto, and M Toda, and E Kou
June 1984, The American journal of cardiology,
T Goto, and K Mitsudo, and K Matsunaga, and O Doi, and Y Nishihara, and J Awa, and T Hase, and T Sakamoto, and M Toda, and E Kou
December 1988, Journal of cardiology,
Copied contents to your clipboard!